Monday, April 8, 2013

Clinical Research Associate or SCRA - INC Research - Jakarta Raya

Advertised:22-03-13 | Closing Date:21-04-13Top HeaderbannerINC Research is a top-tier therapeutically focused global clinical research organization (CRO) providing a complete range of Phase I – Phase IV clinical development services for the world’s biopharmaceutical companies.We proudly boast 43 of the world’s top 50 pharmaceutical companies as our customers. With approximately 5,000 employees across six continents and experience spanning more than 100 countries, we provide significant scale, scope and expertise to deliver innovative clinical development approaches and strategic alliances that meet the needs of our customers.We are currently looking for a Clinical Research Associate II, III or SCRA to join us as a home based monitor in Jakarta, Indonesia.Clinical Research Associate or SCRA
Jakarta Raya


As a CRA II, III or SCRA you will be responsible for:Monitoring all types of clinical trials ensuring adherence to Good Clinical Practices, investigator integrity and compliance with all study proceduresData Handling, Reporting and Tracking & administrative tasksPerforming management of study site activities to ensure the integrity of clinical data, in adherence to all applicable regulatory guidelines.Requirements:

We are seeking candidates with the following key attributes: Education - BS/BA or equivalent with solid clinical trial monitoring experience, demonstrating successful performance of CRA positionPrevious nominal practical experience in conducting clinical pharmaceutical research studies in a hospital setting, pharmaceutical company or CRO preferably.Experience or education indicates a sound basic knowledge of medical and pharmaceutical terminology.In return INC offers a rigorous training program, exposure to international and local studies across multiple therapeutic areas but most important of all. A fun place to work.PLEASE APPLY USING THIS LINK BELOW ONLY:footer

Product reviews and advice for best reference

No comments:

Post a Comment